Characterisation of T cells induced by candidate conserved region HIV-1 vaccines in healthy HIV-1/2 negative volunteers

Characterisation of T cells induced by candidate conserved region HIV-1 vaccines in healthy HIV-1/2 negative volunteers

<p>HIV-1 has claimed the lives of millions of people globally and continues to spread despite development of highly active antiretroviral therapy. In 2013, 2.1 million new infections occurred and over 35 million people were living with HIV-1 infection. A prophylactic HIV-1 vaccine that can pre...

Bibliografski detalji
Glavni autori:	Ahmed, T, Tina Ahmed
Daljnji autori:	Hanke, T
Format:	Disertacija
Jezik:	English
Izdano:	2014
Teme:	Medical Sciences Vaccinology Immunology Infectious diseases HIV/AIDS

Slični predmeti

The design and development of an HIV-1 vaccine to elicit a broadly neutralising antibody response
od: Wan, L, i dr.
Izdano: (2012)

Architecture of the HIV-1 glycan shield
od: Pritchard, L
Izdano: (2014)

HIV-specific interleukin-10 responses and immune modulation
od: Clutton, G
Izdano: (2012)

Antibody-based HIV-1 vaccines: recent developments and future directions
od: Montefiori, D, i dr.
Izdano: (2007)

T-cell receptor (TCR) usage in HIV-2 infection
od: Moysi, E
Izdano: (2012)

Characterisation of the HIV-1 reservoir and the potential for viral eradication
od: Williams, J, i dr.
Izdano: (2014)

T cell responses in Kenyan infants: impact on HIV-1 evolution during infection and an assessment of vaccine-induced memory responses in HIV-exposed uninfected infants
od: Garcia Knight, M
Izdano: (2014)

Identification of immunological targets for HIV-1 vaccine and cure strategies
od: Hancock, G
Izdano: (2014)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
od: Antrobus, R
Izdano: (2014)

Immunodominant CD8+ T cell responses to HIV-1 infection - 'The good and the bad'
od: Culshaw, A
Izdano: (2011)

A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods
od: Warrell, M, i dr.
Izdano: (2008)

Natural and therapy-induced immune control of HIV-1
od: Yager, N
Izdano: (2011)

A study of the phenotype and function of HLA-C restricted CD8 T cells in HIV-1 infection
od: Corrah, TW
Izdano: (2011)

Imaging of HIV-1 spread from T cells and Macrophages to Astrocytes
od: Do, T
Izdano: (2014)

The impact of host and therapy mediated selection on HIV-1 evolution
od: Huang, K
Izdano: (2010)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
od: Harris, S, i dr.
Izdano: (2013)

B cell responses to conjugate and polysaccharide meningococcal vaccines
od: Ramasamy, M
Izdano: (2012)

Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
od: Bauza, K
Izdano: (2012)

The impact of HIV-1 disease and its treatment on mycobacterium tuberculosis-specific immunity
od: Murray, L
Izdano: (2014)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
od: Alharbi, N
Izdano: (2014)

Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
od: Elias, SC
Izdano: (2014)

HLA-B51 associated HIV-1 viral control
od: Peng, Y
Izdano: (2013)

Development of antimalarial human monoclonal antibodies against Plasmodium falciparum
od: Wang, LT
Izdano: (2022)

Host genetic factors and vaccine-induced immunity to hepatitis B virus infection
od: Hennig, B, i dr.
Izdano: (2008)

Towards a universally effective HLA-E-targeted HIV vaccine - a structural and biophysical exploration
od: Walters, L
Izdano: (2019)

Definition of the early HIV-1 signalosome in dendritic cells
od: Khatamzas, E
Izdano: (2013)

Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection
od: Julie L. Mitchell, i dr.
Izdano: (2022-01-01)

Understanding vaccine induced protective immunity to Mycobacterium tuberculosis
od: Ronan, E
Izdano: (2011)

Evaluation of the immunogenicity of a promising vaccine regimen to identify immune correlates of protection
od: Pinpathomrat, N
Izdano: (2018)

Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
od: de Cassan, S
Izdano: (2011)

Understanding the link between interleukin 17 and vaccine-induced protection in tuberculosis
od: Griffiths, K
Izdano: (2012)

Assessment of HIV-1 integration in tissues and subsets across infection stages
od: Vincent H. Wu, i dr.
Izdano: (2020-12-01)

Control of typhoid fever: evaluating herd protection through public health use of typhoid VI polysaccharide vaccine
od: Ochiai, R
Izdano: (2011)

TCF-1 regulates HIV-specific CD8+ T cell expansion capacity
od: Rachel L. Rutishauser, i dr.
Izdano: (2021-02-01)

The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells
od: Gabriel Duette, i dr.
Izdano: (2022-04-01)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response.
od: Matsumiya, M, i dr.
Izdano: (2014)

Innate immune responses to tuberculosis vaccines
od: Matsumiya, M
Izdano: (2014)

Biodegradable pulsatile release technologies for viral vector based vaccinations
od: Krastev, C
Izdano: (2018)

IL-15 enhances HIV-1 infection by promoting survival and proliferation of CCR5+CD4+ T cells
od: Yuhao Li, i dr.
Izdano: (2023-04-01)

Population-specific HLA impact in immune control of HIV in Mexico and non-Mexican HIV infected cohorts
od: Juarez Molina, CI
Izdano: (2014)